Clinical trialNCT00003191CompletedPhase 1Interventional

Fenretinide in Treating Children With Solid Tumors

SponsorNational Cancer Institute (NCI)Enrollment18NeuroblastomaUnspecified Childhood Solid Tumor, Protocol Specific

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Phase I trial to study the effectiveness of fenretinide in treating children who have solid tumors that have not responded to standard therapy. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Judith G. Villablanca, MD
Children's Hospital Los Angeles
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Princess Margaret Hospital for Children
Perth, Western Australia, Australia

United States

Cancer Center and Beckman Research Institute, City of Hope
Duarte, California, United States
Long Beach Memorial Medical Center
Long Beach, California, United States
Children'S Hospital Los Angeles
Los Angeles, California, United States
Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
Children'S Hospital of Orange County
Orange, California, United States
Ucsf Cancer Center and Cancer Research Institute
San Francisco, California, United States
Children'S National Medical Center
Washington D.C., District of Columbia, United States
Indiana University Cancer Center
Indianapolis, Indiana, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
Mayo Clinic Cancer Center
Rochester, Minnesota, United States
Children'S Mercy Hospital
Kansas City, Missouri, United States
Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Herbert Irving Comprehensive Cancer Center
New York, New York, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Nyu School of Medicine'S Kaplan Comprehensive Cancer Center
New York, New York, United States
Children'S Hospital Medical Center - Cincinnati
Cincinnati, Ohio, United States
Children'S Hospital of Columbus
Columbus, Ohio, United States
Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
University of Texas - Md Anderson Cancer Center
Houston, Texas, United States
Primary Children'S Medical Center
Salt Lake City, Utah, United States
Children'S Hospital and Regional Medical Center - Seattle
Seattle, Washington, United States
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

FENRETINIDE

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 1998
Primary completion: 31 Mar 2005
Completion: —
Last update posted: 7 Feb 2013
Registered enrollment: 18
Registry id: NCT00003191

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.